Prophylactic aciclovir (oral or intravenous) vs placebo
Length of hospital stay · Patients being treated for cancer (predominantly haematological malignancies)
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer 2009 · Cochrane All outcomesFor prevention or treatment, no trials reported on duration of hospital stay, amount of analgesia or patient quality of life.0 studiesNo studies found